Market Currents
Raptor Pharmaceuticals (RPTP) +5% AH after announcing FDA acceptance of its New Drug Application...
-
Wednesday, June 13, 2012, 4:36 PM ETRaptor Pharmaceuticals (RPTP) +5% AH after announcing FDA acceptance of its New Drug Application for RP103 for the potential treatment of nephropathic cystinosis.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
